The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality.

[1]  Nelson B Rodrigues,et al.  Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review. , 2021, Journal of affective disorders.

[2]  Nelson B Rodrigues,et al.  The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE) , 2021, Psychiatry Research.

[3]  Nelson B Rodrigues,et al.  Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression , 2021, Advances in Therapy.

[4]  B. Tran,et al.  Cortical haemodynamic response during the verbal fluency task in patients with bipolar disorder and borderline personality disorder: a preliminary functional near-infrared spectroscopy study , 2021, BMC Psychiatry.

[5]  Y. Ning,et al.  Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression , 2021, PeerJ.

[6]  A. Young,et al.  Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. , 2021, The American journal of psychiatry.

[7]  R. McIntyre,et al.  Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials , 2021, CNS Spectrums.

[8]  Nelson B Rodrigues,et al.  Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence , 2020, CNS Spectrums.

[9]  A. Young,et al.  Bipolar disorders , 2020, The Lancet.

[10]  Nelson B Rodrigues,et al.  The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research , 2020, Neuroscience & Biobehavioral Reviews.

[11]  Y. Ning,et al.  Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study , 2020, PeerJ.

[12]  W. Marcantoni,et al.  A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019. , 2020, Journal of affective disorders.

[13]  W. Drevets,et al.  Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II) , 2020, The international journal of neuropsychopharmacology.

[14]  Christopher R. Erbes,et al.  Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. , 2020, Journal of affective disorders.

[15]  Fengchun Wu,et al.  Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis , 2020, Translational Psychiatry.

[16]  P. Brambilla,et al.  Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies. , 2020, Journal of affective disorders.

[17]  Y. Ning,et al.  A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression. , 2020, Journal of affective disorders.

[18]  B. Tran,et al.  Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder , 2020, Scientific Reports.

[19]  W. Tang,et al.  Cognitive impairment in chronic ketamine abusers , 2020, Psychiatry Research.

[20]  Xiang Li,et al.  Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). , 2020, The Journal of clinical psychiatry.

[21]  C. Otte,et al.  Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients. , 2020, Journal of psychiatric research.

[22]  C. Loo,et al.  Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials , 2019, The Australian and New Zealand journal of psychiatry.

[23]  C. Pariante,et al.  Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue , 2019, Brain, Behavior, and Immunity.

[24]  A. Sartorius,et al.  Differences between ketamine’s short-term and long-term effects on brain circuitry in depression , 2019, Translational Psychiatry.

[25]  R. Shelton,et al.  Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. , 2019, The American journal of psychiatry.

[26]  Meng Li,et al.  A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. , 2019, Journal of affective disorders.

[27]  Y. Ning,et al.  Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder , 2019, Psychoneuroendocrinology.

[28]  Y. Ning,et al.  Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. , 2019, Journal of affective disorders.

[29]  Cheng-Ta Li,et al.  Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion. , 2018, Journal of affective disorders.

[30]  Y. Ning,et al.  Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. , 2018, Journal of psychiatric research.

[31]  Y. Ning,et al.  Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression , 2018, Journal of psychopharmacology.

[32]  Jennifer W. Evans,et al.  Ketamine normalizes brain activity during emotionally valenced attentional processing in depression , 2018, NeuroImage: Clinical.

[33]  T. Gould,et al.  Mechanisms of ketamine action as an antidepressant , 2018, Molecular Psychiatry.

[34]  E. Ballard,et al.  The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. , 2017, The American journal of psychiatry.

[35]  K. Miskowiak,et al.  Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field , 2016, European Neuropsychopharmacology.

[36]  B. Baune,et al.  Clinical, Functional, and Biological Correlates of Cognitive Dimensions in Major Depressive Disorder – Rationale, Design, and Characteristics of the Cognitive Function and Mood Study (CoFaM-Study) , 2016, Front. Psychiatry.

[37]  R. McIntyre,et al.  The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials , 2016, The international journal of neuropsychopharmacology.

[38]  N. Ryan,et al.  Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorder , 2016, European Child & Adolescent Psychiatry.

[39]  R. Shelton,et al.  A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. , 2016, The American journal of psychiatry.

[40]  D. Luckenbaugh,et al.  An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder. , 2016, Journal of affective disorders.

[41]  G. Aghajanian,et al.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants , 2016, Nature Medicine.

[42]  R. McIntyre,et al.  The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2015, The international journal of neuropsychopharmacology.

[43]  D. Charney,et al.  Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial , 2015, Neuropsychopharmacology.

[44]  P. Thuras,et al.  Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression. , 2014, The international journal of neuropsychopharmacology.

[45]  R. McIntyre,et al.  A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults , 2014, The international journal of neuropsychopharmacology.

[46]  Benjamin S. Glicksberg,et al.  Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response , 2014, Psychopharmacology.

[47]  Dan V Iosifescu,et al.  Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. , 2013, The American journal of psychiatry.

[48]  Paul Kudlow,et al.  COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS , 2013, Depression and anxiety.

[49]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[50]  K. Waterloo,et al.  Verbal learning and memory in depression: A 9-year follow-up study , 2011, Psychiatry Research.

[51]  Philip D. Harvey,et al.  Effects of lithium on cognitive performance: a meta-analysis. , 2009, The Journal of clinical psychiatry.

[52]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[53]  Charles F Stevens,et al.  Synaptic plasticity , 1998, Current Biology.

[54]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[55]  M. Semkovska,et al.  Cognitive Functioning in the First-Episode of Major Depressive Disorder: A Systematic Review and Meta-Analysis , 2017, Neuropsychology.

[56]  David Rindskopf,et al.  Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis. , 2016, Journal of affective disorders.